Marián Hajdúch: Support for science is actually declining. It pains me to have to turn away talented people
The interview explores declining support for science, genomic projects, the future of cancer screening, and the loss of talented researchers.
Header image
News archive
Rare Disease Day 2026 – Expert meeting & discussion: From diagnosis to treatment
Leading Czech experts will share their insights, including Assoc. Prof. Marián Hajdúch, together with other distinguished specialists on February 25, 2026 in Prague.
World cancer day: The genome as a key to understanding cancer
On the occasion of World Cancer Day (February 4), the National Institute for Cancer Research highlights the importance of genomic data for both prevention and targeted treatment.
Marián Hajdúch discusses how a compound becomes a cancer drug on ČT1 Studio 6
Marián Hajdúch explains how a potential cancer drug is developed, from an initial laboratory compound to an approved medicine. Watch the whole interview in the article.
STRIKE Consortium to meet in Segovia for 6th Progress meeting
On 9 and 10 February 2026, the STRIKE consortium will come together in Segovia for its 6th Progress Meeting, hosted by Nanotech Solutions SL. The meeting will focused on scientific exchange and strategic discussions as the project enters its final year.
9th Advanced In Silico Drug Design workshop 2026
The 9ADD workshop is an international hybrid event hosted by Palacký University Olomouc on 26–30 January 2026. It focuses on modern in silico approaches to drug design.
4th Congress of Airway Diagnostics and Intervention – DIDC 2025
The 4th Congress of Airway Diagnostics and Intervention – DIDC 2025, organised by Platform ‘Zdravé Plíce’ with the support of EATRIS Czech Republic and featured in the EATRIS Spotlight programme. The DIDC 2025 took place on December 1-2, 2025 in Prague.
PhD Club: Development of a protocol for protein corona formation on melamine microparticles and its subsequent processing for LC–MS analysis by Anna Bartáková
December 17, 2025 / 9 AM / 1.09 seminary room
NICR & EATRIS-CZ: Platform for accelerating biomedical innovations
The major research infrastructure EATRIS connects more than 120 research institutions and 11 Czech centers, including NUVR. Together, we build an infrastructure that accelerates the translation of basic research results into clinical practice.
PhD Club: Investigation of Paclitaxel Off-Target Effects and the Anticancer Mechanisms of Artemisinins: Methodological Approaches and Challenges by Ema Heffnerová
Wednesday December 11, 2025 / 9 AM / Seminary room 1.09